INTRODUCTION
Despite advances in HIV prevention over the past 30 years, an estimated 2.5 million persons were newly infected in 2011, bringing the number of people living with HIV worldwide to 34 million. 1 The HIV burden continues to be greatest in sub-Saharan Africa; this region accounts for 75% of all HIV infections and the highest adult prevalence at nearly 5% overall, 1 though this average mask extremes reported in subpopulations, some exceeding 50% infected. 2 The use of antiretroviral treatment (ART) to reduce viral loads and associated transmission risk among sero-discordant couples (Treatment-as-Prevention, TasP) has garnered excitement as a means to curb the spread of the virus. 3 A recent population-based cohort study conducted in a high prevalence region in KwaZulu-Natal found that the risk for HIV acquisition was lowest in areas with the highest ART coverage-providing ecological evidence for real-world effectiveness of TasP. 4 As ART coverage has increased in Africa in the last decade, more HIV-infected individuals have been treated, and life-expectancy of infected individuals has increased. 5 Meanwhile, new transmissions continue, and therefore overall prevalence of HIV can be expected to increase. 6 To sustain an ongoing ART scale-up, and the potential widespread implementation of TasP in the future, expanded financial and public health resources will be required. 7, 8 However, the most biologically effective and financially efficient way to implement and evaluate prevention measures at the population level is unclear.
9,10
Comprehensive knowledge about local epidemics will be required for successful prevention campaigns, including basic data about population demographics, transmission risk groups and viral subtypes, and complex estimates about transmission dynamics, social and sexual mixing networks, and patterns of geographic spread. Importantly, prospective information about success or failure of interventions is essential.
The tools of HIV phylogenetics and molecular epidemiology can be used to understand local transmission dynamics and assist in the design and evaluation of prevention trials. Since early in the epidemic these approaches have been employed to track HIV origin and geographic spread [11] [12] [13] [14] and in forensic studies evaluating small transmission chains. [15] [16] [17] [18] [19] New developments, primarily led by the increased availability of viral
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As for any approach to elucidate HIV transmission patterns, gene sequences can only be generated for those already diagnosed and sampled, and therefore the contribution to transmission from those unsampled, undiagnosed individuals must be considered. Nevertheless, with a well-designed population sampling and sequencing strategy, with linkage to some key demographic, epidemiological and clinical data, questions from all three categories can be addressed for any given population (using the same sequence dataset).
PHYLOGENETIC STUDIES OF TRANSMISSION IN CONCENTRATED EPIDEMICS
Molecular epidemiological tools have been used to address a diverse array of research questions over the last two decades, predominantly in settings with concentrated epidemics. These approaches have advanced to describe transmission dynamics at the local, regional, and national level through the post-hoc utilization of large sequence datasets linked to epidemiological data. These sequence datasets are largely a consequence of routine antiretroviral drug resistance testing that accompanies initial HIV diagnosis, and contains partial HIV pol sequences (typically full protease and partial reverse transcriptase). The pol region has been shown to have sufficient variability to allow for phylogenetic reconstruction to the same extent as the more variable gag and env regions. 21 Studies focused on transmission networks in concentrated epidemics have most commonly been conducted in Europe or North America, where large pol sequence datasets linked with epidemiological data exist (Table 2) .
Basic methodological approach
The basic method to identify HIV transmission dynamics (traits associated with ongoing transmission) is straightforward ( Figure 1 ): 1) HIV gene sequences are used to reconstruct phylogenetic trees or viral transmission networks; 2) transmission clusters are identified from the networks or phylogenies using ad-hoc thresholds for inclusion (e.g. minimum pairwise genetic distance between viral gene sequences, or by statistical robustness of the node that defines a phylogenetic clade); and 3) individual traits are evaluated for the strength of their association with cluster membership and used to infer underlying determinants of transmission. 22, 23 Cluster inclusion thresholds are ad-hoc in the sense that there is no widely accepted 6 threshold definition or determining convention. Variation in threshold definitions and approaches can strongly impact the size and number of inferred clusters in a sequence data set, yet many studies do perform sensitivity analyses to quantitatively assess the impact of this variation on cluster identification in their respective data sets. A recent study of transmission dynamics in Brighton, UK, took this basic methodological approach one step further: clinical data were used to determine the most likely transmitter within transmission pairs or clusters, which allowed for likely onward transmission events (and not simply cluster membership based on pairwise genetic distance) to be evaluated for association with individual traits.
24

What is the contribution of acute and early infection to ongoing transmissions?
Acute HIV infection is generally defined as the time after HIV acquisition but before seroconversion. 
Transmission network analysis
The framework of social network analysis provides an alternative method to understand HIV transmission dynamics, which can be supplemental to the explicitly evolutionary approach of phylogenetic analysis.
Transmission clusters are reconstructed similar to contact tracing, but based on genetic distance metrics.
Transmission network parameters among MSM were estimated using phylodynamics of over 14,000 UKRDB sequences (representing ~60% of UK MSM). 59 Using an inferred network distribution and associated parameter values, the HIV epidemic was characterized by preferential association, which predicted that the epidemic would persist even under conditions of poor overall transmission following a randomly distributed intervention. Cluster growth also differed across the MSM and heterosexual transmission risk groups.
However, the relationship between phylogenetic clusters and sexual networks is not direct (they are not one and the same), and the use of phylogenies to understand the underlying transmission network is complex and requires further elucidation.
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PHYLOGENETICS AND TRANSMISSION DYNAMICS IN GENERALIZED EPIDEMICS OF SUB-SAHARAN
AFRICA: WHAT QUESTIONS CAN BE ADDRESSED?
HIV transmission dynamic studies in concentrated epidemics largely involve the post-hoc use of HIV drug resistance screening datasets whose coverage can reach a substantial proportion of the HIV-infected 9 database currently with >7,000 HIV sequences, albeit sampled from a very large HIV-infected population. 61 Nonetheless, informative phylogenetic analyses of generalized epidemics will still require significant de novo sequencing effort. To enable detailed molecular epidemiological studies to inform prevention, clinical, demographic and behavioral data must be linked to each sequence. This represents a major logistical challenge, given that current sequence databases are generally based on opportunistic approaches to sequence acquisition. Several important questions surrounding HIV epidemiology and prevention can be addressed in the region with available molecular epidemiology tools, particularly when linked to traditional epidemiologic data.
Historical pattern of growth or decline for a given HIV epidemic
Molecular epidemiology and phylogeography can be used to understand historical patterns in epidemic origin, spread, and growth over time and space. The high genetic diversity of HIV-1 Group M has given rise to 9
genetically divergent subtypes (A-D, F-H and J-K), intersubtype recombinants and circulating recombinant forms (CRFs). 62 Sub-Saharan Africa has the highest HIV genetic diversity, and is also characterized by distinct geographical subtype distributions that have remained relatively stable over the past decade. 63 Surveillance of genetic diversity has historically supported tracking global epidemiology 64 and public health strategies to slow further viral spread.
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The integration of time-stamped sequence (those with known dates of sampling) data with phylogenetics, coalescent models and molecular clock models allows inferences to be made on the timing of epidemic origin and spread in Africa. 
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Geographic source of local epidemics or outbreaks
HIV prevalence in Africa is heterogeneously distributed within countries and often communities; epidemics can be overlapping sub-epidemics defined by geography, time, and a complex interplay of local epidemic drivers.
This variation in HIV spread through populations requires that prevention efforts be tailored to characteristics of local epidemics. 1,75 For example, the geographic clustering of HIV along roadways in KwaZulu-Natal indicated the need for more intensified interventions within these communities; this study also indicated that many infections were imported from outside local communities. 76 High transport connectivity and mobile populations may explain the hyper-endemic outbreaks experienced in eastern and southern Africa. 77 Understanding the degree of transmission that occurs from outside communities may have a substantial impact on the design and success of targeted prevention efforts such as TasP.
Communities with high transport connectivity may have local HIV epidemics supported by a significant proportion of transmissions from outside communities. Among 153 HIV pol sequences from patients in one community in rural coastal Kenya, multiple subtypes and significant recombination were documented. 78 In a phylogeographic analysis, many of these sequences were related to different regions in Africa, suggesting multiple introductions into this community, likely reflecting its extensive transport links. In the Rakai district in Uganda, 14,595 individuals in 46 communities underwent extensive HIV surveillance including spatial and phylogenetic transmission linkage analysis. 79 Of 189 HIV-incident cases, an estimated 39% of new cases were infected by household partners, and many new cases that were infected by an extra-household partner were from outside the community. The high degree of external HIV introductions into these communities suggests that the ability of test-and-treat strategies to reduce HIV transmissions may be difficult to measure in small populations unless external introductions are reduced, or unless geographic TasP coverage is sufficiently widespread that migration no longer becomes a relevant problem.
Results from phylogeographic studies must be interpreted in the context of the viral sequences analyzed.
Studies based on convenience samples with limited temporal or spatial scales could lead to erroneous inferences about transmission rates between populations (e.g. between the studied community and the extracommunity). While this potential limitation can be addressed to some extent with extensive sampling of the In contrast to resource-rich settings, drug resistance testing is rarely performed at entry to clinical care, thereby limiting the number of sequences available for phylogenetics. However, sequences will become increasingly available as drug resistance monitoring strategies continue to expand and through ongoing or pending TasP protocols. Phylogenetics could be used to evaluate trends in genetic diversity, further the understanding of
Understanding transmission patterns to help design targeted prevention measures
Targeting epidemic drivers, or core groups, for enhanced prevention may increase the effectiveness of an intervention, but requires detailed epidemiological understanding of viral transmission in the community. This is challenging because HIV transmission dynamics of generalized African epidemics are largely unknown.
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Molecular epidemiological approaches can help uncover local HIV epidemic drivers by contributing the links between overlapping sub-epidemics that are characterized by geography, time and social/sexual interaction. Several combination prevention trials that will assess the impact of TasP on a population level are either planned or are currently in progress in sub-Saharan Africa. Most of these trials have planned or are considering integration of molecular epidemiology analyses (Table 3) .
At the population level, analysis of genetic data can potentially supplement standard approaches to evaluate the impact of an intervention. Comparative phylogenetic analyses of a baseline trial population and the population over the course of a trial can reveal the emergence or disappearance of clusters associated with
A C C E P T E D particular traits. This approach was used to assess the impact of targeted hepatitis B vaccination in The
Netherlands, and showed that resulting decreases in HBV incidence were due largely to declines in intravenous drug or heterosexual (but not MSM) risk groups. 112 However, a follow-up study with increased sample size (n=894, versus n=85) suggested that reduced HBV transmission was in fact due to reduced incidence in MSM, highlighting the importance of sample size and extended sampling periods for studies of this type. 113 Alternatively, gene sequence data can be used to reconstruct HIV transmission networks rather than phylogenies, and cluster size distributions (CSD) can be compared over the course of a prevention trial or intervention. 59, 114, 115 In theory, CSDs will be dominated by larger clusters in populations where epidemic drivers (individuals with relatively high infectiousness) persist. Changes in CSD can reflect an intervention's impact on particular subgroups or the overall transmission patterns. These population level approaches may be most suitable for trials in which clear incidence outcomes are equivocal, or in which there are clear decreases in incidence but the underlying cause is unknown. While the methods can be applied to a trial with any targeting strategy, clinical and demographic data from sequenced individuals are required.
Phylodynamics is the use of pathogen sequences to reconstruct epidemic history using viral genealogies and explicit population genetic models. 114,116,117 Despite great methodological potential and scientific interest, phylodynamics has to date been rarely used for impact evaluation. This is likely related to a lack of consensus about the interpretation of the estimated parameter N e , (nominally the effective population size, a quantity proportional to the number of infected individuals, and estimated by coalescent approaches within the product N e * tau, where tau is the mean (viral) generation time). Estimates of both N e and tau can be strongly affected by epidemic stage, transmission dynamics, or population sampling, 11,118,119 and come with large variances.
There is poor resolution of population size changes in the recent past (~5 years). 119 Additionally, simulation studies have shown that it may be difficult to disentangle the effects of changing incidence and changing transmission networks on phylodynamic parameters; 119,120 information on transmission network structure might be required for accurate parameter estimation. On a positive note, there is a growing base of modeling approaches to understand the relationships between epidemic models, phylogenetics, and transmission networks, which could be utilized to better understand how transmission network structure affects phylogenetic trees, and to model outcomes of specific prevention trial designs. 
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incorporation of stochastic birth-death processes into phylodynamic estimation of epidemic parameters in lieu of standard coalescent models, allowing for more realistic assumptions about changes in epidemic size through time.
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CHALLENGES AND SOLUTIONS FOR IMPLEMENTING PHYLOGENETIC STUDIES IN GENERALIZED EPIDEMICS
Phylogenetic analyses of HIV transmission and other epidemiological questions hold great promise to further our understanding of generalized epidemics and inform prevention efforts. However, we must consider how differences between concentrated and generalized epidemics will affect the design and implementation of such studies. Below we note several key challenges that must be met, followed by potential solutions.
HIV transmission networks will be difficult to detect with limited population sampling
As seen in phylogenetic studies of concentrated HIV epidemics, a large sampling fraction (e.g. >25% of infected individuals in a community) is needed to identify transmission pairs or clusters. This result is seen empirically 24 and in simulations. 121 122 For phylogenetic studies in generalized HIV epidemics, especially in regions where prevalence can exceed 10%, a substantial number of individuals will need to be sampled and sequenced.
Potential solution 1: Population sampling that is biased toward sequencing of incident cases can both decrease the required sample fraction and increase the probability of identifying transmission linkages. This "targeted" sampling strategy contrasts with the opportunistic sampling strategy generally found in standard phylogenetic studies. The approach is suited for studies that seek to identify HIV transmissions, rather than reconstruct viral evolutionary history. As such, phylogenetic studies of transmission will be most informative and efficient when epidemiological questions are not simply overlaid onto ad-hoc phylogenies reconstructed from randomly sampled individuals in a population (the standard approach for phylogenetic studies in e.g.
systematics, biogeography and phylodynamics).
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Potential solution 2: Population sampling conducted over multiple time periods, with the initial sample completed prior to the intervention, increases the probability of identifying transmission pairs or clusters with phylogenetic analysis. Transmission studies in concentrated epidemics generally involve post-hoc use of sequence datasets which allows for retrospective analyses of epidemic history or transmission dynamics. The utility of HIV phylogenetics to inform prevention trials cannot be fully realized, however, based solely on retrospective analyses. The sampling frequency required to improve transmission cluster detection is unclear, and will likely vary according to local incidence rates.
HIV sequencing requirements may be extensive
As large sample fractions will be required for informative phylogenetic analyses of generalized epidemics, significant de novo sequencing effort will be necessary, even with "targeted" sampling of incident infections.
This will require extensive technical capability and ability for large volumes of sequences to be generated relatively rapidly. Except for the SATuRN database, 61 there are no standing HIV sequence databases in the region that can be readily used for molecular epidemiological studies, in contrast to resource-rich settings that have a larger proportion of sequences deposited compared to their epidemic size (Figure 2 ).
Potential solution:
Developing a sequencing pipeline is necessary for large scale HIV phylogenetic and molecular epidemiology projects. Five features of this pipeline are required: 1) the pipeline must work on clinical samples; 2) it must scale across multiple diverse HIV genomes (different subtypes), based on a universal primer set, or alternative methods of genome enrichment that produce equivalent amplification rates across diverse samples; 3) it must scale from 100s to 1000s of samples with ~75% sequencing success rate across a wide range of genome copy number (viral loads of the individual samples); 4) it must produce accurate consensus sequences with no manual editing; 5) it must detect and accurately quantify minority variants; and 6) it must maximize the informative phylogenetic signal, by extending sequencing from one gene (typically the partial pol gene sequenced to around 1kbase length), to the whole viral genome (9.8kbase in length). 131 A component of this solution may be the development in Africa of the capacity for high-throughput full genome HIV sequencing.
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The development of a pan-African sequence database (analogous to the LANL HIV Sequence Database), will provide an important resource for future studies. The few phylogenetic studies of HIV transmission in Africa to date 79, 132 suggest that extra-community HIV transmission sources are common. The potential role of a large pan-African database would be to provide sets of African outgroup sequences, in order to identify extracommunity sources and to clarify their impact vs. undiagnosed local sources. The database would also be useful for studying the spread of inter-subtype recombinants and for characterizing the diversity of regional epidemics in Africa, i.e. for phylodynamics and phylogeography of the African HIV epidemic.
Methodological challenges: Integrating molecular epidemiology into phylodynamics
Molecular epidemiology and phylodynamics have both been areas of active methodological development, as evidenced by the articles referenced above. Nonetheless, current studies in molecular epidemiology that define risk factors for transmission do not make full use of the data available, and do not adequately account for the uncertainty and arbitrariness inherent in clustering.
Potential solution:
A preferable approach would be to integrate the estimation of transmission risk factors (and other statistics of molecular epidemiology) directly into a phylodynamic inference framework, so that all of the data available could be used and arbitrary clustering would not be a prerequisite step. Some authors have begun this process, 133 10%) of the sequences collected will be released, with these sequences chosen at random. This includes location data; one approach is to reduce the resolution of location data by including a set number of individuals (e.g. 200) in the location set, such that individual identification by location is not possible. These data security strategies will also be addressed in the patient consent process and the tight restriction needed on data release must be recognized by funding agencies and scientific journals.
CONCLUSIONS
Opportunities to implement phylogenetic methods at the inception of HIV prevention studies should not be lost.
Progress in computational and analytic techniques for reconstructing HIV phylogenies is ongoing. The costs associated with HIV gene or genome sequencing will continue to decrease; rapid, high-throughput sequencing will produce more sequences and larger databases. These advances make it all but certain that sequences or specimens collected in broad reaching studies will eventually be sequenced and used for phylogenetic analyses. However, planning for such analyses from the beginning will maximize their usefulness and the likelihood that phylogenetic analyses can be used in impact evaluations. Additionally, implementing these analyses prospectively will help in identifying hidden sub-populations or core-transmitter groups, as well as monitoring the spread of transmitted drug resistance, especially among rapidly transmitting networks or 
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